CRISPR-Cas immunity in prokaryotes

Nature. 2015 Oct 1;526(7571):55-61. doi: 10.1038/nature15386.

Abstract

Prokaryotic organisms are threatened by a large array of viruses and have developed numerous defence strategies. Among these, only clustered, regularly interspaced short palindromic repeat (CRISPR)-Cas systems provide adaptive immunity against foreign elements. Upon viral injection, a small sequence of the viral genome, known as a spacer, is integrated into the CRISPR locus to immunize the host cell. Spacers are transcribed into small RNA guides that direct the cleavage of the viral DNA by Cas nucleases. Immunization through spacer acquisition enables a unique form of evolution whereby a population not only rapidly acquires resistance to its predators but also passes this resistance mechanism vertically to its progeny.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • CRISPR-Associated Proteins / metabolism
  • CRISPR-Cas Systems / genetics
  • CRISPR-Cas Systems / immunology*
  • Escherichia coli / genetics
  • Escherichia coli / immunology
  • Escherichia coli / metabolism
  • Escherichia coli / virology
  • Prokaryotic Cells / immunology*
  • Prokaryotic Cells / virology

Substances

  • CRISPR-Associated Proteins